| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0049-3848(99)00059-6 |
| P698 | PubMed publication ID | 10554081 |
| P50 | author | Gabriela F de Larrañaga | Q59001346 |
| P2093 | author name string | L O Carreras | |
| B S Alonso | |||
| R R Forastiero | |||
| P2860 | cites work | Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance | Q33392960 |
| Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders | Q33450363 | ||
| Immunology of the antiphospholipid antibody syndrome | Q41116413 | ||
| Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group | Q43654524 | ||
| Anticardiolipin antibodies (ACA) are most often not associated with lupus-like anticoagulant (LLAC) in human immunodeficiency virus (HIV) infection | Q43909667 | ||
| Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis | Q45282938 | ||
| Measurement of beta 2-glycoprotein I (apolipoprotein H)-independent anticardiolipin antibody in human immunodeficiency virus-1-positive and -negative hemophiliacs | Q45776236 | ||
| Association of human immunodeficiency virus infection and autoimmune phenomena | Q45832998 | ||
| Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus | Q68008000 | ||
| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
| Lupus anticoagulant in the acquired immunodeficiency syndrome | Q70295138 | ||
| Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? | Q72345769 | ||
| Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis | Q72585164 | ||
| Distinguishing beta 2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20 | Q72695657 | ||
| IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients | Q72769511 | ||
| P433 | issue | 1 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 19-25 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome | |
| P478 | volume | 96 |
| Q36247783 | A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006. |
| Q41839818 | Andes virus antigens are shed in urine of patients with acute hantavirus cardiopulmonary syndrome. |
| Q35552173 | Anticardiolipin, anti- 2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease |
| Q36832529 | Antiphospholipid antibodies in response to infection |
| Q35104711 | Antiphospholipid antibodies: discovery, definitions, detection and disease |
| Q33348896 | HIV and autoimmunity |
| Q35153652 | HIV-Associated Venous Thromboembolism |
| Q47877215 | Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis |
| Q33357573 | Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. |
| Q34674429 | Primary anti-phospholipid antibody syndrome (APS): current concepts |
| Q34317744 | The antiphospholipid syndrome and infection |
| Q40047544 | The return of a former foe: syphilis with antiphospholipid syndrome as a cause of acute stroke |
| Q34354700 | Which antiphospholipid antibody tests are most useful? |
Search more.